| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 18 | 2026 | 471 | 2.760 |
Why?
|
| Exotropia | 6 | 2025 | 12 | 2.180 |
Why?
|
| MicroRNAs | 12 | 2026 | 871 | 1.910 |
Why?
|
| Hepatitis B, Chronic | 3 | 2026 | 87 | 1.800 |
Why?
|
| Cell Line, Tumor | 38 | 2026 | 3465 | 1.800 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2025 | 327 | 1.720 |
Why?
|
| Strabismus | 3 | 2023 | 41 | 1.640 |
Why?
|
| Signal Transduction | 31 | 2026 | 4463 | 1.600 |
Why?
|
| Phosphoprotein Phosphatases | 11 | 2021 | 114 | 1.570 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 85 | 1.540 |
Why?
|
| Liver | 9 | 2026 | 1752 | 1.480 |
Why?
|
| Hepatitis B virus | 3 | 2024 | 137 | 1.380 |
Why?
|
| Biomarkers, Tumor | 6 | 2025 | 1570 | 1.360 |
Why?
|
| MAP Kinase Signaling System | 6 | 2026 | 298 | 1.310 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 1386 | 1.280 |
Why?
|
| Cell Movement | 10 | 2026 | 844 | 1.270 |
Why?
|
| Lung Neoplasms | 10 | 2025 | 1488 | 1.180 |
Why?
|
| Polysaccharides | 3 | 2025 | 139 | 1.120 |
Why?
|
| Macrophages | 5 | 2026 | 644 | 1.100 |
Why?
|
| Cell Proliferation | 17 | 2025 | 2393 | 1.100 |
Why?
|
| Exosomes | 2 | 2026 | 57 | 1.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 17 | 2025 | 1931 | 1.060 |
Why?
|
| Esotropia | 3 | 2022 | 10 | 1.050 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2019 | 99 | 1.030 |
Why?
|
| Receptors, Androgen | 5 | 2023 | 398 | 1.030 |
Why?
|
| Hepatocytes | 9 | 2026 | 233 | 1.020 |
Why?
|
| RNA Helicases | 3 | 2022 | 68 | 0.990 |
Why?
|
| Glycomics | 1 | 2025 | 15 | 0.970 |
Why?
|
| Alanine Transaminase | 1 | 2026 | 153 | 0.940 |
Why?
|
| Apoptosis | 12 | 2025 | 1801 | 0.920 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 228 | 0.920 |
Why?
|
| Liver Neoplasms | 3 | 2025 | 1346 | 0.910 |
Why?
|
| Photosensitizing Agents | 1 | 2025 | 37 | 0.890 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2025 | 37 | 0.880 |
Why?
|
| Antineoplastic Agents | 9 | 2025 | 1750 | 0.870 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2025 | 253 | 0.850 |
Why?
|
| Chemical and Drug Induced Liver Injury | 3 | 2020 | 134 | 0.800 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2024 | 139 | 0.790 |
Why?
|
| Interleukin-8 | 4 | 2020 | 203 | 0.770 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 44 | 0.770 |
Why?
|
| Mice | 37 | 2026 | 17578 | 0.760 |
Why?
|
| Humans | 92 | 2026 | 125883 | 0.760 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 136 | 0.760 |
Why?
|
| Machine Learning | 2 | 2025 | 313 | 0.750 |
Why?
|
| NF-kappa B | 4 | 2025 | 438 | 0.730 |
Why?
|
| PAX6 Transcription Factor | 1 | 2021 | 37 | 0.720 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.710 |
Why?
|
| Tongue Neoplasms | 1 | 2021 | 30 | 0.700 |
Why?
|
| Myocytes, Cardiac | 2 | 2024 | 609 | 0.700 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2025 | 415 | 0.680 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 351 | 0.640 |
Why?
|
| Tumor Microenvironment | 7 | 2025 | 622 | 0.640 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2019 | 16 | 0.640 |
Why?
|
| Colorectal Neoplasms | 3 | 2026 | 621 | 0.630 |
Why?
|
| Animals | 45 | 2026 | 33175 | 0.630 |
Why?
|
| Diterpenes | 1 | 2019 | 30 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-ret | 5 | 2024 | 38 | 0.620 |
Why?
|
| Hepatitis B | 2 | 2024 | 166 | 0.610 |
Why?
|
| Liver Failure, Acute | 2 | 2020 | 91 | 0.580 |
Why?
|
| China | 7 | 2023 | 274 | 0.570 |
Why?
|
| Colonic Neoplasms | 3 | 2024 | 249 | 0.570 |
Why?
|
| Epithelial Cells | 2 | 2019 | 871 | 0.550 |
Why?
|
| Carcinogenesis | 2 | 2023 | 340 | 0.530 |
Why?
|
| Retinitis Pigmentosa | 2 | 2014 | 91 | 0.520 |
Why?
|
| Commiphora | 2 | 2013 | 2 | 0.510 |
Why?
|
| Cause of Death | 1 | 2019 | 466 | 0.510 |
Why?
|
| End Stage Liver Disease | 1 | 2019 | 183 | 0.510 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 123 | 0.510 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2024 | 572 | 0.490 |
Why?
|
| Oxidative Stress | 2 | 2020 | 752 | 0.490 |
Why?
|
| Atherosclerosis | 1 | 2024 | 938 | 0.490 |
Why?
|
| Male | 40 | 2026 | 62056 | 0.480 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 746 | 0.480 |
Why?
|
| Smad Proteins | 1 | 2016 | 42 | 0.480 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2024 | 962 | 0.470 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2024 | 639 | 0.470 |
Why?
|
| Acetone | 1 | 2015 | 4 | 0.470 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 3 | 0.470 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 966 | 0.470 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 96 | 0.460 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 46 | 0.460 |
Why?
|
| DNA, Viral | 2 | 2016 | 449 | 0.450 |
Why?
|
| Neoplasms | 4 | 2023 | 2833 | 0.430 |
Why?
|
| Doxorubicin | 3 | 2025 | 288 | 0.430 |
Why?
|
| Pyroptosis | 2 | 2025 | 35 | 0.430 |
Why?
|
| ROC Curve | 2 | 2026 | 566 | 0.420 |
Why?
|
| Reactive Oxygen Species | 5 | 2025 | 488 | 0.420 |
Why?
|
| Triterpenes | 1 | 2013 | 21 | 0.420 |
Why?
|
| Viral Proteins | 1 | 2015 | 336 | 0.410 |
Why?
|
| Heart Failure | 2 | 2024 | 2161 | 0.400 |
Why?
|
| Mice, Nude | 6 | 2025 | 705 | 0.400 |
Why?
|
| Flavonoids | 3 | 2025 | 81 | 0.400 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 103 | 0.400 |
Why?
|
| Female | 33 | 2026 | 67886 | 0.380 |
Why?
|
| HEK293 Cells | 5 | 2021 | 767 | 0.380 |
Why?
|
| Phosphorylation | 11 | 2026 | 1539 | 0.380 |
Why?
|
| Prognosis | 8 | 2025 | 4691 | 0.380 |
Why?
|
| Registries | 1 | 2019 | 1472 | 0.370 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2022 | 251 | 0.370 |
Why?
|
| Lung | 1 | 2019 | 1509 | 0.370 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2025 | 930 | 0.370 |
Why?
|
| Mutation | 6 | 2023 | 5920 | 0.350 |
Why?
|
| Osteoporosis | 2 | 2022 | 131 | 0.350 |
Why?
|
| RNA Interference | 6 | 2020 | 495 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 14 | 2026 | 4503 | 0.350 |
Why?
|
| Interleukin-6 | 5 | 2024 | 405 | 0.350 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 806 | 0.340 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 267 | 0.330 |
Why?
|
| Vision, Binocular | 4 | 2025 | 24 | 0.320 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 536 | 0.320 |
Why?
|
| Computational Biology | 3 | 2025 | 839 | 0.320 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2019 | 233 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2023 | 185 | 0.320 |
Why?
|
| Peptide Fragments | 3 | 2026 | 742 | 0.310 |
Why?
|
| Breast Neoplasms | 5 | 2025 | 2586 | 0.310 |
Why?
|
| Biomarkers | 4 | 2026 | 3139 | 0.300 |
Why?
|
| Middle Aged | 13 | 2026 | 27322 | 0.300 |
Why?
|
| Cell Culture Techniques | 2 | 2023 | 269 | 0.300 |
Why?
|
| Transanal Endoscopic Surgery | 2 | 2018 | 3 | 0.300 |
Why?
|
| Liver Cirrhosis | 2 | 2026 | 871 | 0.290 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 780 | 0.290 |
Why?
|
| Cell Line | 11 | 2018 | 2565 | 0.290 |
Why?
|
| Androgen Antagonists | 3 | 2023 | 104 | 0.280 |
Why?
|
| Sodium Compounds | 2 | 2019 | 9 | 0.280 |
Why?
|
| Arsenites | 2 | 2019 | 18 | 0.270 |
Why?
|
| Gluconeogenesis | 2 | 2018 | 93 | 0.270 |
Why?
|
| Rectal Neoplasms | 2 | 2018 | 77 | 0.270 |
Why?
|
| Neoplasm Metastasis | 4 | 2026 | 681 | 0.260 |
Why?
|
| Phenotype | 3 | 2024 | 4298 | 0.260 |
Why?
|
| Adult | 13 | 2026 | 30246 | 0.250 |
Why?
|
| Chronic Disease | 2 | 2023 | 1177 | 0.250 |
Why?
|
| Blotting, Western | 8 | 2015 | 1019 | 0.250 |
Why?
|
| RNA, Messenger | 4 | 2024 | 2551 | 0.250 |
Why?
|
| Oculomotor Muscles | 3 | 2022 | 58 | 0.250 |
Why?
|
| Hepatitis B e Antigens | 1 | 2026 | 14 | 0.250 |
Why?
|
| Keratin-18 | 1 | 2026 | 10 | 0.250 |
Why?
|
| RNA Polymerase II | 2 | 2025 | 90 | 0.250 |
Why?
|
| Diet, High-Fat | 2 | 2026 | 238 | 0.240 |
Why?
|
| Depth Perception | 1 | 2025 | 13 | 0.240 |
Why?
|
| Contrast Sensitivity | 1 | 2025 | 42 | 0.240 |
Why?
|
| Periodontitis | 1 | 2025 | 21 | 0.240 |
Why?
|
| Cardiotoxicity | 2 | 2017 | 40 | 0.240 |
Why?
|
| Flavanones | 1 | 2025 | 8 | 0.240 |
Why?
|
| Rhinitis, Allergic | 1 | 2025 | 15 | 0.240 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2025 | 37 | 0.230 |
Why?
|
| Mice, SCID | 3 | 2022 | 564 | 0.230 |
Why?
|
| Versicans | 1 | 2025 | 15 | 0.230 |
Why?
|
| Nanocomposites | 1 | 2025 | 7 | 0.230 |
Why?
|
| Androgens | 3 | 2023 | 267 | 0.230 |
Why?
|
| Tensins | 1 | 2025 | 3 | 0.230 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 1211 | 0.230 |
Why?
|
| Chlorophyllides | 1 | 2025 | 3 | 0.230 |
Why?
|
| Cell Differentiation | 4 | 2023 | 1850 | 0.230 |
Why?
|
| Graphite | 1 | 2025 | 14 | 0.230 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2025 | 20 | 0.230 |
Why?
|
| THP-1 Cells | 1 | 2024 | 20 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2025 | 57 | 0.220 |
Why?
|
| Gene Expression Profiling | 4 | 2025 | 1779 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2026 | 168 | 0.220 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 53 | 0.220 |
Why?
|
| Gene Frequency | 3 | 2015 | 739 | 0.220 |
Why?
|
| Photochemotherapy | 1 | 2025 | 41 | 0.220 |
Why?
|
| Benzamides | 2 | 2023 | 118 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2025 | 480 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 436 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2024 | 14 | 0.220 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2025 | 66 | 0.220 |
Why?
|
| Pyridones | 2 | 2016 | 124 | 0.220 |
Why?
|
| Insulin Resistance | 3 | 2026 | 668 | 0.220 |
Why?
|
| Smad1 Protein | 2 | 2014 | 22 | 0.220 |
Why?
|
| Gene Expression | 5 | 2023 | 1489 | 0.220 |
Why?
|
| Thioctic Acid | 1 | 2024 | 7 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2025 | 204 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 2330 | 0.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2025 | 123 | 0.210 |
Why?
|
| Biopsy | 2 | 2026 | 1219 | 0.210 |
Why?
|
| Dynamins | 1 | 2024 | 45 | 0.210 |
Why?
|
| Butyric Acid | 1 | 2024 | 7 | 0.210 |
Why?
|
| Tissue Scaffolds | 1 | 2025 | 91 | 0.210 |
Why?
|
| Rhabdomyosarcoma | 3 | 2016 | 209 | 0.210 |
Why?
|
| Transcriptome | 3 | 2025 | 1064 | 0.210 |
Why?
|
| Mitochondrial Dynamics | 1 | 2024 | 48 | 0.210 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 1 | 2023 | 9 | 0.210 |
Why?
|
| HMGB1 Protein | 1 | 2023 | 25 | 0.210 |
Why?
|
| Histone Deacetylase 2 | 1 | 2023 | 15 | 0.210 |
Why?
|
| Neovascularization, Physiologic | 1 | 2025 | 198 | 0.210 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 16 | 0.210 |
Why?
|
| Glutamine | 1 | 2025 | 195 | 0.210 |
Why?
|
| Interleukin-4 | 1 | 2024 | 143 | 0.210 |
Why?
|
| Kallikreins | 2 | 2021 | 27 | 0.210 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2023 | 28 | 0.210 |
Why?
|
| Interleukin-13 | 1 | 2024 | 94 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2024 | 86 | 0.200 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2023 | 42 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 636 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 446 | 0.200 |
Why?
|
| Killer Cells, Natural | 1 | 2025 | 333 | 0.200 |
Why?
|
| Aconitate Hydratase | 1 | 2023 | 11 | 0.200 |
Why?
|
| Interferon-alpha | 1 | 2024 | 235 | 0.200 |
Why?
|
| Water | 1 | 2024 | 189 | 0.200 |
Why?
|
| Homeostasis | 2 | 2024 | 685 | 0.200 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2021 | 84 | 0.190 |
Why?
|
| Arabidopsis Proteins | 1 | 2023 | 56 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 2 | 2024 | 1211 | 0.190 |
Why?
|
| Nanoparticles | 1 | 2025 | 265 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2019 | 581 | 0.190 |
Why?
|
| Osteoporotic Fractures | 1 | 2022 | 27 | 0.190 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2023 | 84 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 233 | 0.190 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 426 | 0.190 |
Why?
|
| Learning | 1 | 2025 | 355 | 0.190 |
Why?
|
| Wearable Electronic Devices | 1 | 2024 | 113 | 0.190 |
Why?
|
| Arabidopsis | 1 | 2023 | 89 | 0.190 |
Why?
|
| Microglia | 1 | 2023 | 129 | 0.190 |
Why?
|
| Cryptocarya | 1 | 2021 | 1 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2317 | 0.180 |
Why?
|
| Isoquinolines | 1 | 2021 | 39 | 0.180 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2021 | 12 | 0.180 |
Why?
|
| Autophagy | 3 | 2020 | 402 | 0.180 |
Why?
|
| Alkaloids | 1 | 2021 | 36 | 0.180 |
Why?
|
| Young Adult | 9 | 2022 | 9583 | 0.180 |
Why?
|
| Child | 10 | 2025 | 25059 | 0.180 |
Why?
|
| Eye | 1 | 2023 | 217 | 0.180 |
Why?
|
| Tongue | 1 | 2021 | 29 | 0.180 |
Why?
|
| Wound Healing | 1 | 2025 | 445 | 0.180 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 68 | 0.180 |
Why?
|
| Nitrogen | 2 | 2014 | 121 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 398 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 48 | 0.170 |
Why?
|
| Retrospective Studies | 8 | 2022 | 16775 | 0.170 |
Why?
|
| Genome-Wide Association Study | 3 | 2024 | 1721 | 0.170 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2021 | 62 | 0.170 |
Why?
|
| Child, Preschool | 8 | 2025 | 14341 | 0.170 |
Why?
|
| Lignans | 1 | 2020 | 5 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 441 | 0.170 |
Why?
|
| Lactams | 1 | 2020 | 19 | 0.170 |
Why?
|
| Neuropeptides | 1 | 2021 | 112 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 1178 | 0.160 |
Why?
|
| Cyclin B1 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Protein Phosphatase 2C | 3 | 2016 | 59 | 0.160 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 601 | 0.160 |
Why?
|
| Molecular Structure | 3 | 2021 | 305 | 0.160 |
Why?
|
| Eye Proteins | 1 | 2021 | 228 | 0.160 |
Why?
|
| Chemokine CCL20 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Acute Disease | 2 | 2022 | 1039 | 0.160 |
Why?
|
| Pedigree | 2 | 2021 | 1655 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 247 | 0.160 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 86 | 0.160 |
Why?
|
| Exome | 2 | 2014 | 1065 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 324 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2019 | 111 | 0.150 |
Why?
|
| Sirolimus | 2 | 2012 | 224 | 0.150 |
Why?
|
| Adolescent | 9 | 2025 | 19934 | 0.150 |
Why?
|
| Survival Analysis | 3 | 2020 | 1473 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2025 | 822 | 0.150 |
Why?
|
| Intelligence | 1 | 2019 | 91 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 720 | 0.150 |
Why?
|
| Liver Function Tests | 1 | 2019 | 98 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 975 | 0.150 |
Why?
|
| Glycogen | 2 | 2015 | 50 | 0.150 |
Why?
|
| Confidence Intervals | 1 | 2019 | 257 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 655 | 0.140 |
Why?
|
| Gene Products, env | 1 | 2018 | 16 | 0.140 |
Why?
|
| Caspase 3 | 2 | 2020 | 125 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2026 | 1548 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2025 | 5090 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3705 | 0.140 |
Why?
|
| Hippocampus | 1 | 2023 | 772 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 539 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 205 | 0.140 |
Why?
|
| Quinazolines | 1 | 2019 | 178 | 0.140 |
Why?
|
| Tissue Adhesives | 1 | 2018 | 34 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2019 | 306 | 0.140 |
Why?
|
| Indoles | 1 | 2019 | 197 | 0.140 |
Why?
|
| Transfection | 2 | 2017 | 949 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 234 | 0.140 |
Why?
|
| Multiprotein Complexes | 2 | 2016 | 193 | 0.140 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 77 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 169 | 0.140 |
Why?
|
| Age Distribution | 1 | 2019 | 415 | 0.140 |
Why?
|
| Cytokines | 1 | 2024 | 1316 | 0.140 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 881 | 0.140 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2018 | 100 | 0.140 |
Why?
|
| Drug Resistance | 1 | 2018 | 248 | 0.140 |
Why?
|
| Interferon-gamma | 1 | 2020 | 518 | 0.140 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 793 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 185 | 0.130 |
Why?
|
| Piperidines | 1 | 2019 | 216 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2024 | 1035 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 318 | 0.130 |
Why?
|
| Heart Function Tests | 1 | 2017 | 49 | 0.130 |
Why?
|
| Asthma | 1 | 2024 | 761 | 0.130 |
Why?
|
| RNA, Viral | 2 | 2016 | 511 | 0.130 |
Why?
|
| Databases, Genetic | 2 | 2020 | 482 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3652 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2025 | 1879 | 0.130 |
Why?
|
| Macaca mulatta | 1 | 2018 | 482 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 63 | 0.130 |
Why?
|
| Retroviridae | 1 | 2017 | 180 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2021 | 887 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 2 | 2019 | 722 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2018 | 179 | 0.130 |
Why?
|
| Glucose | 2 | 2018 | 845 | 0.130 |
Why?
|
| Incidence | 3 | 2019 | 3192 | 0.120 |
Why?
|
| Laparoscopy | 2 | 2018 | 516 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2026 | 2348 | 0.120 |
Why?
|
| Cohort Studies | 3 | 2025 | 4890 | 0.120 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 130 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cytosol | 1 | 2016 | 139 | 0.120 |
Why?
|
| Ebolavirus | 1 | 2016 | 46 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 348 | 0.120 |
Why?
|
| Twist-Related Protein 1 | 1 | 2016 | 34 | 0.120 |
Why?
|
| Isoleucine-tRNA Ligase | 1 | 2015 | 1 | 0.120 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2015 | 23 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2917 | 0.120 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 58 | 0.120 |
Why?
|
| Protein Binding | 3 | 2014 | 1673 | 0.120 |
Why?
|
| Urethane | 1 | 2015 | 6 | 0.120 |
Why?
|
| Codon, Terminator | 1 | 2015 | 26 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 572 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 512 | 0.120 |
Why?
|
| Anoikis | 1 | 2015 | 8 | 0.120 |
Why?
|
| Glycogenolysis | 1 | 2015 | 10 | 0.120 |
Why?
|
| Endoderm | 1 | 2015 | 23 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 161 | 0.120 |
Why?
|
| Virus Replication | 1 | 2018 | 593 | 0.110 |
Why?
|
| Activins | 1 | 2015 | 72 | 0.110 |
Why?
|
| Curcumin | 1 | 2015 | 42 | 0.110 |
Why?
|
| Astragalus Plant | 1 | 2014 | 2 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 128 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 168 | 0.110 |
Why?
|
| Cholestasis | 1 | 2017 | 164 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2015 | 204 | 0.110 |
Why?
|
| Treatment Outcome | 5 | 2023 | 12354 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 821 | 0.110 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2014 | 34 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2016 | 307 | 0.110 |
Why?
|
| Smad8 Protein | 1 | 2014 | 5 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2016 | 217 | 0.110 |
Why?
|
| Quinoxalines | 1 | 2014 | 37 | 0.110 |
Why?
|
| Peptides | 1 | 2018 | 826 | 0.110 |
Why?
|
| Smad5 Protein | 1 | 2014 | 21 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 721 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 103 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2025 | 167 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2018 | 651 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2016 | 262 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 162 | 0.110 |
Why?
|
| Plant Exudates | 1 | 2013 | 2 | 0.110 |
Why?
|
| Survival Rate | 1 | 2019 | 2054 | 0.100 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 706 | 0.100 |
Why?
|
| I-kappa B Kinase | 2 | 2016 | 56 | 0.100 |
Why?
|
| Artemisinins | 1 | 2013 | 11 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 66 | 0.100 |
Why?
|
| Rats | 4 | 2025 | 3390 | 0.100 |
Why?
|
| Dietary Supplements | 1 | 2017 | 436 | 0.100 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2013 | 84 | 0.100 |
Why?
|
| Caspase 9 | 1 | 2013 | 75 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2002 | 0.100 |
Why?
|
| Aged | 6 | 2025 | 20022 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 296 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2017 | 377 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 725 | 0.100 |
Why?
|
| Phylogeny | 1 | 2015 | 718 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 526 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 3 | 2025 | 372 | 0.100 |
Why?
|
| Nickel | 1 | 2012 | 21 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1306 | 0.100 |
Why?
|
| Genotype | 2 | 2016 | 2599 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2012 | 8 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 405 | 0.090 |
Why?
|
| Copper | 1 | 2012 | 72 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2025 | 1001 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1236 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 661 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2012 | 314 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 237 | 0.090 |
Why?
|
| Smad2 Protein | 1 | 2011 | 49 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2011 | 52 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 363 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 757 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 28 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2013 | 584 | 0.090 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 26 | 0.090 |
Why?
|
| Pyrroles | 1 | 2012 | 176 | 0.090 |
Why?
|
| Terpenes | 1 | 2011 | 30 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1294 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2011 | 45 | 0.080 |
Why?
|
| Cholesterol | 1 | 2013 | 547 | 0.080 |
Why?
|
| Software | 1 | 2015 | 711 | 0.080 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 33 | 0.080 |
Why?
|
| Proteolysis | 2 | 2024 | 177 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2017 | 2902 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 1608 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2019 | 3417 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 3249 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 911 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2011 | 558 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2023 | 829 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 505 | 0.070 |
Why?
|
| Immunotherapy | 2 | 2024 | 737 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 522 | 0.070 |
Why?
|
| Rectum | 2 | 2018 | 99 | 0.070 |
Why?
|
| Visual Acuity | 2 | 2025 | 644 | 0.070 |
Why?
|
| Phosphorus | 1 | 2008 | 60 | 0.070 |
Why?
|
| Cell Survival | 2 | 2025 | 833 | 0.070 |
Why?
|
| Soil | 1 | 2008 | 73 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2023 | 1014 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 148 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2023 | 1132 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 192 | 0.060 |
Why?
|
| Mice, Obese | 2 | 2017 | 72 | 0.060 |
Why?
|
| RAW 264.7 Cells | 1 | 2026 | 47 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 135 | 0.060 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 238 | 0.060 |
Why?
|
| Base Sequence | 3 | 2017 | 2772 | 0.060 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2015 | 6 | 0.060 |
Why?
|
| Exhalation | 1 | 2025 | 12 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2016 | 87 | 0.060 |
Why?
|
| Particle Size | 1 | 2025 | 131 | 0.060 |
Why?
|
| Chitosan | 1 | 2025 | 29 | 0.060 |
Why?
|
| Nasal Mucosa | 1 | 2025 | 76 | 0.060 |
Why?
|
| Drug Carriers | 1 | 2025 | 114 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 93 | 0.060 |
Why?
|
| Breath Tests | 1 | 2025 | 182 | 0.060 |
Why?
|
| Random Allocation | 2 | 2016 | 419 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2025 | 403 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 299 | 0.050 |
Why?
|
| Elastomers | 1 | 2024 | 4 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2024 | 87 | 0.050 |
Why?
|
| Troponin T | 1 | 2025 | 218 | 0.050 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2024 | 20 | 0.050 |
Why?
|
| Glycyrrhizic Acid | 1 | 2023 | 3 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2023 | 17 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2024 | 330 | 0.050 |
Why?
|
| Risk Factors | 4 | 2022 | 10351 | 0.050 |
Why?
|
| Brassinosteroids | 1 | 2023 | 1 | 0.050 |
Why?
|
| Plant Growth Regulators | 1 | 2023 | 8 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2025 | 276 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Niacinamide | 1 | 2023 | 30 | 0.050 |
Why?
|
| Temperature | 1 | 2024 | 285 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 770 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2023 | 60 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 993 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2023 | 63 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 169 | 0.050 |
Why?
|
| Radius | 1 | 2022 | 35 | 0.050 |
Why?
|
| Blood Cells | 1 | 2022 | 55 | 0.050 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 132 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 219 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 164 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 515 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 313 | 0.050 |
Why?
|
| Optical Rotation | 1 | 2021 | 1 | 0.050 |
Why?
|
| Glucosidases | 1 | 2021 | 3 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1236 | 0.050 |
Why?
|
| Glycoside Hydrolase Inhibitors | 1 | 2021 | 6 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 1589 | 0.050 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2021 | 24 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 84 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 2018 | 2978 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2023 | 321 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1382 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3297 | 0.040 |
Why?
|
| Neurons | 1 | 2011 | 1908 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 317 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2023 | 677 | 0.040 |
Why?
|
| Chromones | 1 | 2020 | 24 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 44 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 50 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 277 | 0.040 |
Why?
|
| Morpholines | 1 | 2020 | 60 | 0.040 |
Why?
|
| Protective Agents | 1 | 2020 | 36 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2022 | 294 | 0.040 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2020 | 15 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 34 | 0.040 |
Why?
|
| Bone Density | 1 | 2022 | 351 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2020 | 64 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 102 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 62 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 231 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2019 | 59 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 611 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 158 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 60 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 2104 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 59 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2020 | 142 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 133 | 0.040 |
Why?
|
| Laparoscopes | 1 | 2018 | 5 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 215 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 82 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 115 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2018 | 56 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2018 | 29 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 79 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 141 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 365 | 0.040 |
Why?
|
| Antagomirs | 1 | 2017 | 2 | 0.040 |
Why?
|
| Oligoribonucleotides | 1 | 2017 | 8 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2017 | 5 | 0.040 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2017 | 17 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2020 | 415 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 43 | 0.030 |
Why?
|
| Operative Time | 1 | 2018 | 193 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 96 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 363 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 168 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2018 | 298 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 27 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2017 | 22 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 58 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 1025 | 0.030 |
Why?
|
| Sierra Leone | 1 | 2016 | 19 | 0.030 |
Why?
|
| Sendai virus | 1 | 2016 | 4 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2016 | 16 | 0.030 |
Why?
|
| Octoxynol | 1 | 2016 | 7 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 373 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 54 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6571 | 0.030 |
Why?
|
| Gene Order | 1 | 2016 | 80 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1193 | 0.030 |
Why?
|
| Viral Load | 1 | 2018 | 400 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 4423 | 0.030 |
Why?
|
| Emmetropia | 1 | 2015 | 4 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 92 | 0.030 |
Why?
|
| Pyridazines | 1 | 2016 | 51 | 0.030 |
Why?
|
| Diplopia | 1 | 2015 | 25 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 137 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2016 | 52 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 188 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 89 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2015 | 74 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 228 | 0.030 |
Why?
|
| DNA Damage | 1 | 2018 | 490 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2744 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 332 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2017 | 131 | 0.030 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 239 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 2015 | 10 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2015 | 18 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 325 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 330 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 9 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 508 | 0.030 |
Why?
|
| Imidazoles | 1 | 2016 | 212 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 245 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2015 | 38 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Imines | 1 | 2014 | 10 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 243 | 0.030 |
Why?
|
| Cyclization | 1 | 2014 | 17 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 65 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 362 | 0.030 |
Why?
|
| Oxides | 1 | 2014 | 16 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 68 | 0.030 |
Why?
|
| Hydrogen | 1 | 2014 | 42 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 18 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1703 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 266 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 455 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 111 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 118 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 413 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 257 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 356 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 104 | 0.030 |
Why?
|
| Nitriles | 1 | 2014 | 141 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 609 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 224 | 0.030 |
Why?
|
| Carbon | 1 | 2014 | 88 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 160 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 182 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 398 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 425 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 584 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 277 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 58 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 160 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 105 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 605 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 1313 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1601 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 213 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 891 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2012 | 113 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 133 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1132 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2014 | 303 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 1009 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1819 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 160 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2550 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 112 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 115 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2013 | 421 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 283 | 0.020 |
Why?
|
| Family | 1 | 2014 | 575 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2033 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3600 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2010 | 11 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 396 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11149 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 44 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1597 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2010 | 241 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 240 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 658 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 564 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2863 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 52 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 380 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 55 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 93 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 344 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 560 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 689 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1374 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2508 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3571 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 12776 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 6024 | 0.010 |
Why?
|